reactogenicity

reactogenicity

(rē-ak-tō-je-nĭ-sĭ'tē),
State of being able to produce adverse reactions.

reactogenic

(rē-ak″tŏ-jen′ik) [ react(ion) + -genic]
Capable of producing a physiologic response, as a vaccine that elicits an antibody response.
reactogenicity (-jĕ-nis′ĭt-ē)
Mentioned in ?
References in periodicals archive ?
This flu vaccine study is called "A Phase II, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial to Assess the Safety, Reactogenicity, and Immunogenicity of Two Doses of Multimeric-001 (M-001) Followed by Seasonal Trivalent Influenza Vaccine.
Thesensitins from epizootic strains of mycobacteria were tested in terms of such criteria as sterility, safety, reactogenicity, lack of sensitizing properties, activity, and specificity.
For example, one concern that arises is reactogenicity and inflammation.
Safety and reactogenicity data were collected and reviewed by an independent data and safety monitoring board.
Giving a lower dose to young children was planned to reduce reactogenicity and febrile convulsions observed with the whole virus vaccines that were in use in the 1970s.
The primary outcome measure was to compare the reactogenicity and immunogenicity between the monovalent and multivalent vaccines from the results of the available clinical trials.
Reactogenicity and safety were assessed as secondary objectives and included solicited adverse events (AEs) (reactogenicity) for four days post-vaccination and unsolicited AEs, serious AEs (SAEs) and medically-attended AEs (MAEs) for 21 days post-vaccination.
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies," Vaccine, vol.
This ChAd3 Ebola candidate vaccine has shown encouraging immune responses and an acceptable safety and reactogenicity profile in ongoing Phase I trials to date.